Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing
Author:
Affiliation:
1. Mayo Clinic Arizona Mayo Clinic Arizona Scottsdale USA
2. Yale Neurology New Haven CT USA
3. Lundbeck Seattle BioPharmaceuticals, Inc. Bothell WA USA
4. Pacific Northwest Statistical Consulting, Inc. Woodinville WA USA
Publisher
Wiley
Subject
Neurology (clinical),Neurology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/head.14007
Reference36 articles.
1. Patients' Preference for Migraine Preventive Therapy
2. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
3. Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
4. Preventive migraine treatment;Silberstein SD;Continuum (Minneap Minn),2015
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial;European Journal of Neurology;2023-11-13
2. Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab;Pain and Therapy;2023-06-22
3. Patterns of response to anti‐calcitonin gene‐related peptide monoclonal antibodies during first 6 months of treatment in resistant migraine patients: Impact on outcome;European Journal of Neurology;2023-04-26
4. Is the right way to go in between?;The Journal of Headache and Pain;2023-03-30
5. Anwendung monoklonaler Antikörper zur Migräneprophylaxe in der Praxis;InFo Neurologie + Psychiatrie;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3